Smoking attributable mortality in the community of Madrid: 1992-1998

European Journal of Public Health

Volumn 15, Issue 1, 2005, Pages 43-50

  Zorrilla Torras, Belén ^a,b   García Marín, Natividad ^a   Galán Labaca, Iñaki ^a   Gandarillas Grande, Ana ^a  

^a Dirección General de Salud Pública   (Spain)

^b Servicio de Sanidad Ambiental Instituto de Salud Pública   (Spain)

Author keywords

Attributable mortality; Tobacco; Trends

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER MORTALITY; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENDER; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PUBLIC HEALTH; REGRESSION ANALYSIS; RISK ASSESSMENT; SEX DIFFERENCE; SPAIN;

ADULT; AGE DISTRIBUTION; CAUSE OF DEATH; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POISSON DISTRIBUTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEX DISTRIBUTION; SMOKING; SPAIN;

EID: 16844361864     PISSN: 11011262     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurpub/cki110     Document Type: Article

References (52)

1. Health For All Data Base European Region. Update: January 2003. World Health Organization Regional Office for Europe.
2. Lopez AD, Collishaw NE, Piha T. A descriptive model of the cigarette epidemic in developed countries. Tobacco Control 1994;3:242-7.
3. Ronnenberg A, Lund KE, Hafstad A. Lifetime smoking habits among Norwegian men and women born between 1890 and 1974. Int J Epidemiol 1994;23:267-75.
4. Graham H. Smoking prevalence among women in the European Community 1950-1990. Soc Sci Med 1996;43(2):143-54.
5. Garfinkel L. Trends in cigarette smoking in the United States. Prev Med 1997;26:447-50.
6. Harris JE. Cigarette smoking among successive birth cohorts of men and women in the United States during 1900-80. J Natl Cancer Inst 1983;7:473-8.
7. Tabacalera SA. Series históricas de consumo de tabaco elaborado 1957-1991. Madrid: Tabapress, 1992.
8. Ministerio de Trabajo y Seguridad Social. Dirección General de Salud Pública. Boletín Epidemiológico Semanal. No 1502. Madrid 1985.
9. Fernandez E, Schiaffino A, García M, Saltó E, Villalbí JR, Borrás JM. Smoking in Spain,1945-1995. A retrospective analysis based on the Spanish Nacional Health Interview Surveys. Med Clin (Barc) 2003;120(1):14-16.
10. Regidor E, Gutierrez-Fisac JL. Indicadores de Salud. Ministerio de Sanidad y Consumo, Madrid, 1999.
11. Consejería de Sanidad, Vigilancia del Consumo de Tabaco y Mortalidad Atribuible. Boletín Epidemiológico de la Comunidad de Madrid 2001; 7 (1): 3-38.
12. Third Action Plan for tobacco-free Europe 1997-2001. World Health Organitation. Regional Office for Europe.: EUR/ICP/LVNG 01 04 01
13. Gil E, González J, Villar F, et al. Informe sobre la salud de los Españoles: Ministerio de Sanidad y Consumo, Madrid 1999
14. Office on Smoking and Health National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention (CDC): Smoking-Attributable Mortality, Morbidity, and Economic Cost (SAMMEC), version 3.0 [Software and Documentation.] US Department of Health and Human Services, Agosto, 1996.
15. Romeder JM, Mc Whinnie JR. Potential years of life lost between ages 1 and 70: an indicador of premature mortality for health planning. Int J Epidemiol 1977;6:143-57, 151.
16. Centers for Diseases Control and Prevention. Cigarette-smoking attributable mortality and years of potential life lost-US, 1990. Morbidity and Mortality Weekly Report 1993;Vol. 42:645-9.
17. Ministerio de Sanidad y Consumo. Madrid, 1989. Encuesta Nacional de Salud, 1987.
18. Ministerio de Sanidad y Consumo. Madrid, 1995. Encuesta Nacional de Salud de España, 1993.
19. US Department Of Health And Human Services, Reducing the Health Consequences of Smoking: 25 years of progress. A report of the Surgeon General. DHHS Publication number (CDC) 1989 89-8441
20. González J, Villar F, Banegas JR, Rodríguez F, Martín JM. Trends in the mortality attributable to tobacco use in Spain, 1978-1992: 600,000 deaths in 15 years. Med Clin (Barc) 1997;109:577-82.
21. Consell Assessor sobre tabaquisme a Catalunya. Mortalitat, morbiditat i cost atribuibles al tabac a Catalunya. En: Dona i tabac. Direcció General de Salut Publica. Generalitat de Catalunya. Departament de Sanitat y Seguretat Social. Barcelona, 2001.
22. Banegas JR, Díez L, Rodríguez F, González J, et al. Smoking-attributable deaths in Spain in 1998. Med Clin (Barc) 2001;117:692-4.
23. González J, Rodríguez F, Martín J, Banegas JR, Villar F. Deaths attributable to tobacco consumption in Spain. Med Clin (Barc) 1989;92:15-18.
24. Rodríguez R, Bueno A, Pueyos A, et al. Morbidity, mortality and the potential years of life lost attributable to tobacco. Med Clin (Barc) 1997;108:121-7.
25. Bello LM, Lorenzo P, Gil M, Saavedra P, Serra L. Evolution of mortality attributable to tobacco in the Canary Islands (1975-1994). Rev Esp Salud Pública 2001;75:71-80.
26. Peto R, Lopez AD, Boreham J, Thun M, Heath C. Mortality from smoking in developed countries 1950-2000. Indirect estimates from National Vital Statistics. Oxford University Press, 1994.
27. Centers for Diseases Control and Prevention. Cigarette smoking-attributable mortality and years of potential life lost-United States, 1990. J Am Med Assoc 1993;270:1408-13.
28. Centers for Diseases Control and Prevention. Annual smoking-attributable mortality, years of potential life lost, and economic costs. United States, 1995-1999.
29. Makomaski M, Kaiserman J. Mortality attributable to tobacco use in Canada and its Regions, 1991. Can J Public Health 1995:257-65.
30. Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case control studies. BMJ 2000;321:323-9.
31. Li CY, Lin RS. Risk assessment of active smoking: smoking-attributable mortality and years of potential life lost in Taiwan, 1980 and 1992. Asia Pacific Public Health 1980;9:13-17, 1996-97.
32. Martínez, M., Gandarillas, A., Galán, I. Consejería de Sanidad de la Comunidad de Madrid. Dirección General de Salud Pública. Epidemiología de las enfermedades cardiovasculares en la Comunidad de Madrid. Documentos técnicos de Salud Pública No 30.
33. Dirección General de Salud Pública Consejería de Sanidad de la Comunidad de Madrid. Mortalidad por enfermedades no transmisibles en la Comunidad de Madrid, 1997. Boletín Epidemiológico de la Comunidad de Madrid 2001; 7: 4-34.
34. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, et al. Estimation of the contribution of changes in classic risk factors to trends in coronary event rates across the WHO MONICA Project populations. Lancet 2000;355:675-87.
35. Capewell S, Morrison CE, McMurray JJ. Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975-1994. Heart 1999;81:380-6.
36. Olalla MT, Medrano MJ, Sierra MJ, Almazán J. Time trends cohort effect and spatial distribution of cerebrovascular disease mortality in Spain. Eur J Epidemiol 1999;15:331-8.
37. Borrás JM, Fernandez E, Gonzalez JR, et al. Lung Cancer mortality in European regions (1955-1997). Ann Oncol 2003;14:159-61.
38. Thun MJ, Day-Lally CA, Calle E, Flanders WD, Heath CW. Excess mortality among cigarrette smokers: changes in a 20-year interval. Am J Public Health 1995;85:1223-30.
39. Wise RA. Changing smoking patterns and mortality from chronic obstructive pulmonary diseases. Prev Med 1997;26(4):418-21.
40. Davis RM, Novotny TE. The epidemiology of cigarette smoking and its impact on chronic obstructive pulmonary diseases. Am Rev Respir Dis 1989;140:S82-4.
41. Kuller LH, Ockene JK, Mkeihlan E, Wentworth DN, Svendsen KH, Neaton JD. Cigarette smoking and mortality. MRFIT research group. Prev Med 1991;20:636-54.
42. Brennan P, Bray I. Recent trends and future direction for lung cancer mortality in Europe. Br J Cancer 2002;87(1):43-8.
43. Tyczynski JE, Bray F, Parkin DM. Lung Cancer in Europe in 2000: epidemiology, prevention and early detection. The Lancet Oncol 2003;4:45-55.
44. Jansen-Hejnem MLG, Coebergh JW. Trends in incidence and prognosis of the histological subtypes of lung cancer in North-America. Australia, New Zealand and Europe. Lung Cancer 2001;31:123-37.
45. Thun MJ, Apicella LF, Henley SJ. Smoking over other risk factors as the cause of smoking attributable deaths. J Am Med Assoc 2000;284:706-12.
46. Malarcher A, Svhullman J, Epstein L, Thun MJ, Pierce B, Escobedo L, Giovino G. Methodological issues in estimating smoking attributable mortality in the United States. Am J Epidemiol 2000;152:573-83.
47. Sterling TD, Rosenbaum WL, Weinkman JJ. Risk attribution and tobacco related deaths. Am J Epidemiol 1993;138(2):128-39.
48. Corrao G, Rubbiata L, Zambon S, Aricò S. Alcohol-attributable and alcohol-preventable mortality in Italy: a balance in 1983 and 1996. Eur J Public Health 2002;12(3):214-23.
49. Lopez-Abente G, Pollan M, Monge V, Martinez Vidal A. Tobacco smoking, alcohol consumption and laryngeal cancer in Madrid. Cancer Detect Prev 1992;16(5-6):265-71.
50. Choi SY, Kahio H. Effect of cigarette smoking and alcohol consumption in the aethiology of cancer of the oral cavity, pharynx and larynx. Int J Epidemiol 1991;20(4):878-85.
51. World Health Organization. Adult per capita Alcohol consumption (http://www3.who.int/whisis/alcohol).
52. International Agency for Research on Cancer: Tobacco smoking and tobacco smoke. Summary of Data Reported and Evaluation (http://www-cie.iarc.fr/hdocs/ monographs/vol83/01-smoking.html).